These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34787051)

  • 1. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
    Li L; Li Q
    Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
    Ren X; Li A; Ying E; Fang J; Li M; Yu J
    Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 6. miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells.
    Cao W; Ni L; Li P; Wang QX; Li MM; Huang SH; Dang NN
    Technol Cancer Res Treat; 2022; 21():15330338221082431. PubMed ID: 35243940
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
    Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
    Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
    Li Y; Yang X; Lu D
    Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-942 regulates the function of breast cancer cell by targeting FOXA2.
    Zhang J; Zhang Z; Sun J; Ma Q; Zhao W; Chen X; Qiao H
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31701999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T.
    Wang F; Zhong S; Mao C; Jin J; Wang H
    Ann Hepatol; 2022; 27(5):100722. PubMed ID: 35569812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-511 inhibits proliferation and metastasis of breast cancer cells by targeting FGF4.
    Zhang C; Yang T; Jiang H
    J Gene Med; 2020 Sep; 22(9):e3168. PubMed ID: 32023352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
    Liu F; Zhu C; Gao P; Zheng S; Li C
    Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Wang X; Zhou X; Zeng F; Wu X; Li H
    Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer.
    Li L; Wei D; Zhang J; Deng R; Tang J; Su D
    Comput Math Methods Med; 2022; 2022():5203839. PubMed ID: 35069784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
    Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.